BRIEF published on 03/31/2025 at 09:09, 8 months 4 days ago Elumeo SE Announces Restructuring and Forecast Adjustment Restructuring Elumeo SE Financial Forecast Gemstone Jewelry #Juwelo100
PRESS RELEASE published on 03/31/2025 at 09:04, 8 months 4 days ago EQS-Adhoc: elumeo SE decides on restructuring program of EUR 5.9 million for 2025 and lowers forecast for 2024 elumeo SE announces a EUR 5.9 million restructuring program for 2025 and revises down 2024 forecast, focusing on higher-priced jewelry and cost-cutting measures Elumeo SE Cost-cutting Measures Restructuring Program Jewelry Market 2025 Forecast
BRIEF published on 11/14/2024 at 08:05, 1 year ago Elumeo SE Maintains Stability in Challenging Q3/2024 Market Elumeo SE Q3 2024 Cost Management Gemstone Jewelry Consumer Confidence
PRESS RELEASE published on 11/14/2024 at 08:00, 1 year ago elumeo SE continues to hold its own in Q3/2024 in a persistently difficult market en-vironment elumeo SE maintains stability in Q3/2024 despite challenging market conditions with sales almost steady at EUR 33.0 million and positive adjusted EBITDA of EUR 0.44 million Adjusted EBITDA Market Conditions Elumeo SE Sales Stability Q3/2024
BRIEF published on 10/25/2024 at 07:46, 1 year 1 month ago Elumeo SE Announces Capital Increase with 250,000 New Shares European Market Capital Increase Elumeo SE Equity Ratio Gemstone Jewelry
PRESS RELEASE published on 10/25/2024 at 07:41, 1 year 1 month ago EQS-Adhoc: elumeo SE: Capital increase of 250,000 shares at EUR 2 per share Berlin, 25 October 2024 elumeo SE resolves capital increase of 250,000 shares at EUR 2 per share to improve equity ratio. New shares issued to strategic investor. Dividend rights from 1 Jan 2024 Shares Capital Increase Elumeo SE Equity Ratio Dividend Rights
BRIEF published on 10/04/2024 at 09:44, 1 year 2 months ago Elumeo SE Revises 2024 Forecast Amid Economic Challenges Cost Reduction Elumeo SE 2024 Forecast Consumer Confidence Internationalization 2.0
PRESS RELEASE published on 10/04/2024 at 09:39, 1 year 2 months ago elumeo SE adjusts forecast for 2024 due to the economic situation – cost reduction program ahead of plan elumeo SE adjusts forecast for 2024 citing economic situation. Cost reduction program progresses ahead of schedule, impacting revenue, margin, and EBITDA outlook Revenue Cost Reduction Forecast Elumeo SE Economic Situation
BRIEF published on 10/04/2024 at 09:27, 1 year 2 months ago Elumeo SE Revises 2024 Financial Forecast Adjusted EBITDA Elumeo SE Sales Decline Financial Forecast Cost-cutting
PRESS RELEASE published on 10/04/2024 at 09:22, 1 year 2 months ago EQS-Adhoc: elumeo SE adjusts forecast for 2024 elumeo SE adjusts forecast for 2024, expecting a slight decline in sales, gross profit margin, and adjusted EBITDA. Measures in place to cut costs and increase savings Financial Year Forecast Adjustment Elumeo SE Sales Decline Cost-cutting Program
Published on 12/05/2025 at 02:35, 3 hours 52 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 27 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 22 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 27 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 57 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 36 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 2 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 12 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 17 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 27 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 42 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 43 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 26 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
